Rapport Therapeutics Inc....

NASDAQ: RAPP · Real-Time Price · USD
14.66
-0.28 (-1.87%)
At close: Aug 15, 2025, 3:59 PM
14.57
-0.61%
After-hours: Aug 15, 2025, 05:51 PM EDT

Rapport Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Net Income
-26.73M -24.06M -19.98M -17.54M -18.12M -22.67M -13.52M -8.71M -6.41M -6.15M
Depreciation & Amortization
252K 244K 260K 219K 208K 152K 53K 23K 21K 15K
Stock-Based Compensation
4.39M 4.04M 3.21M 3.18M 2.35M 1.49M 998K 859K 945K 723K
Other Working Capital
-4.4M -618K 693K 3.23M -217K -2.02M 1.22M 1.65M -1.15M -422K
Other Non-Cash Items
391K -25K 725K -5.56M -670K 6.57M 167K 119K 987K 1.78M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-3.37M -433K 1.34M 3.28M -123K -3.16M 1.94M 2.28M -1.15M -422K
Operating Cash Flow
-25.07M -20.24M -14.45M -16.41M -16.35M -17.61M -10.36M -5.42M -6.6M -4.8M
Capital Expenditures
-22K -291K -226K -140K -967K -1.07M -1.44M -52K -86K -61K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-12.95M -43.67M -84.56M -113.51M -138.43M -44.8M -77.22M n/a n/a n/a
Sales Maturities Of Investments
35.48M 64.56M 116.72M 56.84M 32.29M 3.95M n/a n/a n/a n/a
Other Investing Acitivies
92K 436K n/a 3.77M n/a n/a n/a n/a n/a n/a
Investing Cash Flow
22.6M 21.03M 31.93M -53.04M -107.1M -41.93M -78.66M -52K -86K -61K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a -1K n/a n/a n/a n/a n/a -4K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 221.63M n/a 283K -283K -134K 58K -40K -18K
Financial Cash Flow
-63K 5K 7K -1.39M 159.35M 63.66M -140K 85.36M -90K 60.01M
Net Cash Flow
-2.54M 799K 17.49M -70.85M 35.9M 4.12M -89.16M 79.88M -6.78M 55.14M
Free Cash Flow
-25.09M -20.53M -14.67M -16.55M -17.32M -18.69M -11.79M -5.48M -6.68M -4.86M